当前位置: 首页 > 期刊 > 《中国保健营养》 > 2013年第11期 > 正文
编号:12711019
不同年龄组子宫内膜癌患者胰岛素抵抗状况的比较分析(2)
http://www.100md.com 2013年6月1日 曲军卫
第1页

    参见附件。

     [5] Mu N,Zhu Y,Wang Y,et al.Insulin resistance:a significant risk factor of endometrial cancer[J].Gynecol Oncol,2012,125(3):751-757.

    [6] Soumaya K.Molecular mechanisms of insulin resistance in diabetes[J].Adv Exp Med Biol,2012,771:240-251.

    [7] Zhang Z,Zhou D,Lai Y,et al.Estrogen induces endometrial cancer cell proliferation and invasion by regulating the fat mass and obesity-associated gene via PI3K/AKT and MAPK signaling pathways[J].Cancer Lett,2012,319(1):89-97.

    [8] Gunter MJ,Hoover DR,Yu H,et al.A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer[J].Cancer Epidemiol Biomarkers Prev,2008,17(4):921-929.

    [9] Cantrell LA,Zhou C,Mendivil A,et al.Metformin is a potent inhibitor of endometrial cancer cell proliferation-implications for a novel treatment strategy[J].Gynecol Oncol,2010,116(1):92-98.

    [10] Stanosz S.An attempt at conservative treatment in selected cases of type I endometrial carcinoma(stage I a/G1)in young women[J].Eur J Gynaecol Oncol,2009,30(4):365-369.

您现在查看是摘要介绍页,详见PDF附件